Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
The global burden of renal diseases is increasingly severe, underscoring the need for in-depth exploration of the molecular mechanisms underlying renal disease progression and the development of potential novel biomarkers or therapeutic targets. Angiopoietin-like protein 4 (ANGPTL4) is a multifuncti...
Saved in:
| Main Authors: | Yan Li, Yuxin Zhang, Mengxia Cao, Tingting Yuan, Santao Ou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1475198/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients
by: Yan Wang, et al.
Published: (2024-12-01) -
Advancements in the non-invasive diagnosis of renal fibrosis
by: Tingting Yuan, et al.
Published: (2025-07-01) -
Angiopoietin-like4 can be used to evaluate and predict efficacy for membranous nephropathy
by: WANG Jian, et al.
Published: (2019-01-01) -
Research progress on the association between TMAO and vascular calcification in patients with chronic kidney disease
by: Yuxin Zhang, et al.
Published: (2024-12-01) -
Recent Advancements in Understanding the Role and Mechanisms of Angiopoietin-like Proteins in Diabetic Retinopathy
by: Xinling Zhang, et al.
Published: (2025-05-01)